Fortinet’s Ken Xie Reappointed to the U.S. – Brazil CEO Forum

Building on His Initial Appointment to the Position, Fortinet CEO Will Continue to Provide U.S. Private Sector Expertise to Forum and Develop Joint Policy Recommendations Impacting the Future of Infrastructure, Technology, and Workforce Development in Both Countries

SUNNYVALE, Calif., March 06, 2023 (GLOBE NEWSWIRE) —

Ken Xie, Founder, Chairman of the Board and Chief Executive Officer at Fortinet
“I am honored to be reappointed to the U.S.-Brazil CEO Forum and to continue to work alongside the Honorable Gina Raimondo, U.S. Secretary of Commerce, and other global business leaders. At Fortinet we recognize the importance of private and public sector partnerships to help disrupt cybercrime and to build the future workforce through cyber training initiatives. As part of the Forum, I look forward to facilitating information sharing and contributing best practices to protect against cyber threats that jeopardize the global economy and that of Brazil.”

News Summary
Fortinet® (NASDAQ: FTNT), the global cybersecurity leader driving the convergence of networking and security, today announced Ken Xie, Founder, Chairman of the Board, and Chief Executive Officer (CEO), has once again been appointed by the Honorable Gina M. Raimondo, U.S. Secretary of Commerce, to the U.S. – Brazil CEO Forum. Xie will be joining other chief executives of American and Brazilian companies to develop joint recommendations on how to increase bilateral trade and investments.

Global Leadership and Partnerships Across Sectors
Established in 2007, the U.S.-Brazil CEO Forum – consisting of up to 12 CEO representatives from each country – convenes business leaders to offer collective suggestions to strengthen the economic and commercial partnership between the U.S. and Brazil. Prior recommendations from Forum members have propelled discussions between the two governments regarding significant matters such as education, energy, trade facilitation, and infrastructure. Through Xie’s participation in the Forum, Fortinet will continue to deepen its collaboration between private and public sectors.

Fortinet Stands For More Than Just Technology Innovation
As part of Fortinet’s Corporate Social Responsibility efforts, the company is committed to making the world a safer and more sustainable place by reducing cyber risks for society and helping organizations address today’s most pressing cyber challenges. To help advance this mission, Fortinet is dedicated to cross-industry threat sharing and global partnerships with government organizations, global law enforcement and industry organizations, including being a founding partner of the WEF Centre for Cybersecurity, an active contributor of WEF’s Partnership against Cybercrime (PAC), a long-standing member of the NATO Industry Cyber Partnership (NICP), a partner of the National Cybersecurity Excellence Partnership (NCEP) program, and more.

Additionally, Fortinet is increasing access to its industry-recognized training and multi-level certifications through the Fortinet Training Institute and Training Advancement Agenda (TAA) initiatives to help organizations combat the growing cyber skills gap affecting the industry.

Fortinet was also recently named to the 2022 Dow Jones Sustainability Index (DJSI) World and DJSI North America ranking among the global top sustainable companies in the software and services industry. This milestone further underscores the company’s ongoing commitment to sustainability practices and ability to deliver impact through its Corporate Social Responsibility approach.

Additional Resources

About Fortinet
Fortinet (NASDAQ: FTNT) is a driving force in the evolution of cybersecurity and the convergence of networking and security. Our mission is to secure people, devices, and data everywhere, and today we deliver cybersecurity everywhere you need it with the largest integrated portfolio of over 50 enterprise-grade products. Well over half a million customers trust Fortinet’s solutions, which are among the most deployed, most patented, and most validated in the industry. The Fortinet Training Institute, one of the largest and broadest training programs in the industry, is dedicated to making cybersecurity training and new career opportunities available to everyone. FortiGuard Labs, Fortinet’s elite threat intelligence and research organization, develops and utilizes leading-edge machine learning and AI technologies to provide customers with timely and consistently top-rated protection and actionable threat intelligence. Learn more at https://www.fortinet.com, the Fortinet Blog, and FortiGuard Labs.

FTNT-O

Copyright © 2023 Fortinet, Inc. All rights reserved. The symbols ® and ™ denote respectively federally registered trademarks and common law trademarks of Fortinet, Inc., its subsidiaries and affiliates. Fortinet’s trademarks include, but are not limited to, the following: Fortinet, the Fortinet logo, FortiGate, FortiOS, FortiGuard, FortiCare, FortiAnalyzer, FortiManager, FortiASIC, FortiClient, FortiCloud, FortiMail, FortiSandbox, FortiADC, FortiAI, FortiAIOps, FortiAntenna, FortiAP, FortiAPCam, FortiAuthenticator, FortiCache, FortiCall, FortiCam, FortiCamera, FortiCarrier, FortiCASB, FortiCentral, FortiConnect, FortiController, FortiConverter, FortiCWP, FortiDB, FortiDDoS, FortiDeceptor, FortiDeploy, FortiDevSec, FortiEdge, FortiEDR, FortiExplorer, FortiExtender, FortiFirewall, FortiFone, FortiGSLB, FortiHypervisor, FortiInsight, FortiIsolator, FortiLAN, FortiLink, FortiMoM, FortiMonitor, FortiNAC, FortiNDR, FortiPenTest, FortiPhish, FortiPlanner, FortiPolicy, FortiPortal, FortiPresence, FortiProxy, FortiRecon, FortiRecorder, FortiSASE, FortiSDNConnector, FortiSIEM, FortiSMS, FortiSOAR, FortiSwitch, FortiTester, FortiToken, FortiTrust, FortiVoice, FortiWAN, FortiWeb, FortiWiFi, FortiWLC, FortiWLM and FortiXDR. Other trademarks belong to their respective owners. Fortinet has not independently verified statements or certifications herein attributed to third parties and Fortinet does not independently endorse such statements. Notwithstanding anything to the contrary herein, nothing herein constitutes a warranty, guarantee, contract, binding specification or other binding commitment by Fortinet or any indication of intent related to a binding commitment, and performance and other specification information herein may be unique to certain environments.

Media Contact: Investor Contact: Analyst Contact:
Stephanie Lira Peter Salkowski Brian Greenberg
Fortinet, Inc. Fortinet, Inc. Fortinet, Inc.
408-235-7700 408-331-4595 408-235-7700
pr@fortinet.com psalkowski@fortinet.com analystrelations@fortinet.com

GlobeNewswire Distribution ID 8781971

Clinical evidence presented at ACC.23/WCC highlights how utilization of Philips cardiology solutions is improving the quality and efficiency of patient care

March 6, 2023

  • Preliminary results of large-scale real-world data study of Medicare patients conclude that use of intravascular imaging (IVI) during percutaneous coronary intervention (PCI) procedures grew 62% between 2013 and 2019, and is associated with lower incidence of mortality, acute myocardial infarction (MI), repeat PCI, and major adverse cardiac event (MACE) 
  • Largest real-world Medicare analysis of Cardiac Implantable Electronic Device (CIED) infection treatment in more than 1 million patients shows that early removal of infected cardiac implantable electronic devices (CIEDs), for which Philips developed the Philips Laser Sheath – GlideLight – and Philips Mechanical Rotating Dilator Sheath – TightRail, substantially improves healthcare utilization and reduces hospital costs
  • Multi-center, prospective, observational study demonstrates the safety and procedural efficiency of Philips Intracardiac Echocardiography (ICE) Catheter – VeriSight Pro 3D ICE  

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the presentation of various clinical study results at this year’s Annual Scientific Session & Expo of the American College of Cardiology/World Congress of Cardiology event (ACC.23/WCC, March 4 – 6, New Orleans, USA) that confirm Philips’ commitment to clinically validating its innovations in cardiac and cardiovascular care.

  • Initial results from a high-quality real-world evidence study of Medicare data (inpatient and outpatient, 2013-2019) by Dr. Eric Secemsky, Director of Vascular Intervention at Beth Israel Deaconess Medical Center (BIDMC, Boston, MA, USA), that analyzed over a million patients to evaluate trends in the use of, and outcomes associated with, intravascular imaging (IVI) during percutaneous coronary intervention (PCI) procedures were presented by Dr. Reza Fazel, Interventional Cardiologist at BIDMC.
  • Dr. Sean Pokorney, Assistant Professor of Medicine and Member of the Duke Clinical Research Institute at Duke University School of Medicine (Durham, NC, USA), presented the results of a study that quantified the improved healthcare utilization and reduced hospital costs associated with early removal of infected cardiac implantable electronic devices (CIEDs).
  • A presentation by Dr. Mohamad Alkhouli, Professor of Medicine at Mayo Clinic School of Medicine (Rochester, MN, USA) detailed the results of a study that demonstrated the real-world safety and performance of Philips Intracardiac Echocardiography Catheter – VeriSight Pro 3D ICE – during a range of image-guided minimally-invasive cardiac procedures.

“To make a real difference to patients, it is vitally important that medical innovations are validated in real-life clinical practice so that clinician decision-making and guideline setting are firmly evidence-based. At Philips, we are deeply committed to making sure this is the case,” said Dr. Atul Gupta, Chief Medical Officer for Image-Guided Therapy at Philips. “The positive clinical study results announced today are further evidence of how we are continuously working with our clinical partners to co-create new innovations and demonstrate how they improve outcomes for patients.”

Reduced risk of one-year mortality when intravascular imaging used during PCI procedures
Dr. Eric Secemsky at Beth Israel Deaconess Medical Center and his collaborators conducted a high-quality real-world evidence study of Medicare data for over one million patients undergoing PCI procedures between January 1, 2013, and December 31, 2019. The preliminary results, which were presented at ACC.23/WCC by Dr. Reza Fazel, reveal that the use of intravascular imaging (IVI) technologies as an adjunct to angiography rose by 62% during the period and is associated with superior patient outcomes. The potential for further strong growth is supported by a recent review published in the Journal of the American College of Cardiology (JACC), which “advocates broader use of these technologies as a part of contemporary practice” and recommends that “IVI capability should be included in all U.S. CCLs [cardiac catheterization laboratories]” [1]. Dr. Fazel’s presentation highlighted some of the benefits that could accrue from such a move. The retrospective real-world study showed that IVI use during PCI procedures was associated with lower rates of one-year mortality (Hazard Ratio 0.96, 95% CI 0.94-0.98)**, myocardial infarction (MI), repeat PCI procedures, and major adverse cardiac event (MACE). It is one of the first studies to include outpatient procedures, which accounted for 43.3% of all the PCIs included in the analysis.

Philips’ IVI offering comprises a range of intravascular ultrasound (IVUS) catheters, co-registration and automated measurement tools for use on Philips Image-Guided Therapy System – Azurion, designed to help cardiologists decide, guide, and confirm the right interventional treatment for each patient. The patient benefits of these tools have already been demonstrated in multiple clinical studies. The JACC review paper referred to above states that IVUS is “the more flexible of the options and is the one that can be utilized in almost all clinical scenarios” [1].

Timely removal of infected CIEDs  
The CIED Infection Medicare Study* of clinical practice was conducted by Dr. Sean Pokorney and his team at the Duke Clinical Research Institute, which analyzed the records of more than one million CIED implant patients in the ‘U.S. 100% Medicare fee-for-service’ population covering the period January 1, 2006, to December 31, 2019.

The study represented a nationwide analysis of CIED infection care, and as already reported by Dr. Pokorney at last year’s ACC (ACC.22) [2], demonstrated that approximately 4 in 5 patients were not treated [2] according to ACC/AHA/HRS/EHRA Class I consensus recommendations and guidelines for CIED infection, which recommend full system extraction ideally within 3 days [3,4]. Of the 9,867 patients diagnosed with a CIED infection 12 months or more after implantation, only 13.3% underwent extraction within six days and only 5.2% between seven and 30 days.

“This data highlights a major gap in care among our CIED infection patients, which results in higher mortality, more health care utilization, and higher cost of care. Quality improvement interventions with focused systems of care are needed to optimize patient outcomes,” commented Dr. Pokorney.

Dr. Pokorney’s presentation at ACC.23/WCC highlighted the cumulative incidence of all-cause hospitalization and the associated healthcare expenditure for these patients during a period of one year after infection diagnosis. Complete device extraction within six days of CIED infection diagnosis was associated with lower all-cause hospitalization in follow-up (21% lower) and lower healthcare expenditure (42% lower) compared with patients who did not undergo extraction [5]. Timely extraction was also associated with lower hospitalization rates. The patient group for which no device extraction within 30 days of diagnosis took place was characterized by a 68% hospitalization rate compared to a 54% hospitalization rate for the group in which patients underwent CEID extraction within six days of diagnosis. Additionally, hospital expenditures in the year following a CIED infection were almost cut in half, with costs being USD 63,259 for the group with no extraction within 30 days, reducing to USD 36,815 for extraction within six days.

Dr. John Andriulli added: “CIED infection is a healthcare crisis and EMR (electronic medical records) are essential in identifying patients and minimizing time to extraction.  It must be ubiquitously shared between hospital systems to improve length of stay and more importantly to impact the potential reduction in mortality. This is especially true for outside hospital transfers. This is when the EMR becomes even more important.”

Performance and safety of 3D intracardiac echocardiography
The prospective, non-randomized, multi-center, observational study*** into the safety and performance of Philips 3D Intracardiac Echocardiography Catheter (ICE) – VeriSight Pro – was led by Dr. Mohamad Alkhouli at Mayo Clinic School of Medicine. The study was based on a cohort of 155 patients evaluated for a range of percutaneous cardiac intervention procedures, including left atrial appendage occlusion (LAAO), cardiac ablation, heart valve replacement, and patent foramen ovale (PFO) as well as atrial septal defect (ASD) ‘hole-in-the-heart’ repair procedures.

Compared to TEE, which involves passing an ultrasound transducer deep into the patient’s esophagus, an ICE catheter has a tip-mounted ultrasound transducer that can be routed to the heart via the patient’s blood vessels and a small incision in the skin. For the majority of patients, ICE is considerably more comfortable than TEE and requires less sedation or anesthesia, improving patient safety and experience and reducing the number of operating room staff required during a procedure.

During the study, patients were followed until discharge or 48 hours after their procedure, with safety demonstrated by the fact that no periprocedural device-related adverse events were reported. Philips VeriSight Pro 3D ICE demonstrated acceptable or better image quality compared to TEE or competitive ICE technology in over 95% of the procedures. VeriSight Pro 3D ICE was considered to be an acceptable or better surrogate to TEE 89.7% of the time.

All three clinical studies are part of more than 110 ongoing clinical studies that support Philips image-guided therapy solutions with clinical evidence. For ten consecutive years, Philips has been recognized as a top innovator in the Clarivate Top 100 Global Innovator list.

For more information on innovation at Philips, click here.

*Supported by a research grant from Philips. Philips had no role in the design of the study or conduct of the analysis.
**In the Secemsky study, the Hazard Ratio of 0.96 implies that patients undergoing PCI using angiography and IVI imaging during PCI have a 4% lower risk of dying during the following year than patients undergoing PCI using angiography alone.
***Philips sponsored and developed the Philips Intracardiac Echocardiograhy (ICE) Clinical Registry, NCT 04950192

[1] Truesdell A, Alasnag M, Kaul P, et al. Intravascular Imaging During Percutaneous Coronary Intervention. J Am Coll Cardiol. 2023 Feb, 81 (6) 590–605.
[2] Pokorney SD. Low Rates Of Guideline Directed Care Associated With Higher Mortality In Patients With Infections Of Pacemakers And Implantable Cardioverter Defibrillators. American College of Cardiology (ACC) Late Breaking Clinical Trials. Washington, DC, USA April 2022 [presentation].
[3] Kusumoto et al. 2017 HRS Expert Consensus Statement on Cardiovascular Implantable Electronic Device Lead Management and Extraction. Heart Rhythm, 2017.
[4] Blomström-Lundqvist, C., et al. (2020, Jun 1). European Heart Rhythm Association (EHRA) international consensus document on how to prevent, diagnose, and treat cardiac implantable electronic device infections -endorsed by HRS, APHRS, LAHRS, ISCVID, ESCMID in collaboration with EACTS. Eur Heart J, 41(21), 2012-2032.
[5] Pokorney SD. Healthcare utilization and healthcare expenditures in patients with infections of pacemaker and implantable cardioverter defibrillators. American College of Cardiology (ACC) Scientific Sessions. New Orleans, USA March 2023 [presentation].

For further information, please contact:
Joost Maltha
Philips Global Press Office
Tel: +31 6 10 55 8116
Email: joost.maltha@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2022 sales of EUR 17.8 billion and employs approximately 77,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

GlobeNewswire Distribution ID 1000796476

Webtel.mobi and its US Subsidiary – WM Holdings Inc. – publish articles on why Currently-Envisaged CBDCs Do Not Exist and Cannot Be Created, and Detailing their Unitary Global Digital Currency

Global Digital Currencies. New Way = Progress. Old Way = Dead End

Global Telephony Provider Webtel.mobi and its US Subsidiary WM Holdings Inc. – which have created the world’s first fully-functional Unitary Global Digital Currency equivalent and Unitary Global Clearing System equivalent – detail, from practical experience, why Currently-Envisaged CBDCs are impossible to create, and detail the Structure, Functionality and Capacities of their Unitary Global Digital Currency and Unitary Global Clearing System

LONDON and NEW YORK, March 06, 2023 (GLOBE NEWSWIRE) —

Global Digital Currencies. New Way = Progress. Old Way = Dead EndWebtel.mobi Details How and Why the New Way of Solving the Global Digital Currency Requirement was Successful

For over 10 years, and at a cumulative cost of well over USD 1 Trillion, entities worldwide have been proposing the creation of a “CBDC” Digital Currency, with its stated purpose being to bring various advantages to the Global Financial and Economic Systems – either for the entities running the system, or for the public at large.

So far, to date, and despite this long passage of time and extraordinary expense, not one functioning “CBDC” instrument – as currently-envisaged – has been created worldwide, and there is no sign that one will be created at all.

In fact, in Webtel.mobi’s review of claimed “Operational CBDCs” or “In-Process CBDCs” to date, its findings indicate that what has been created so far are either:

  1. Local internet-accessible variants of existing Central Bank Digital Currencies (which have, in fact, already existed for decades) that are – like pre-19th Century Currencies – restricted to local use, or
  2. Digital Payment Systems, that are not even internationalized in the manner that already-old Payment Services Providers’ Digital Payment Systems already are, or
  3. Systems that actually run off the existing infrastructures of the already-old Payment Services Providers’ Digital Payment System networks.

This situation raises fundamental questions relating to the credibility of statements to date – as well as ongoing statements – by entities who continue to cling to the “Old Way”, relating to their “completed” or “imminent” implementation of such currently-envisaged CBDC instruments, as well as questions related to the future of the global digitalization of currency. Among others these questions include:

  1. Why and how is it that after such a long time, and at such extraordinary cost, no functioning CBDC as currently-envisaged has been created – rather entering into the twilight world inhabited by all of the many other previous quests for a “Global Currency” / “One World Currency” / “Universal Digital Currency” ?
  2. Is it even possible to create a Unitary Global Digital Currency?
  3. If it is, how could it be achieved, and what would the results and ramifications of such an instrument encompass?

Webtel.mobi and its US Subsidiary WM Holdings Inc., which – following a “New Way” – have in fact already created, and run, the world’s first Tested, Due Diligenced, Proven and Fully Operational Unitary Global Digital Currency; provide the answers to these questions; and also provide the details – in their experience – as to:

  1. Why it is impossible to create a “CBDC” as currently-envisaged.
  2. What is required to create a Unitary Global Digital Currency – as already created by Webtel.mobi.
  3. The results and Global Ramifications of the creation and operation of the world’s first fully-operational Unitary Global Digital Currency, and the Unitary Global Clearing System in which it is operational.

In a two-Part Article, now being released for public review, these details reveal with clear factual descriptions the issues faced with regard to attempts to create CBDCs as currently-envisaged.

They also describe the capacities and advantages of Webtel.mobi’s existing Unitary Global Digital Currency – which not only renders the concepts of currently-envisaged CBDCs redundant before they are created; but furthermore encompass far-advanced capacities of the currently-envisaged CBDCs, and allows all entities to immediately commence use thereof as “their own” National or Currency-specific CBDCs without incurring any systemic risk.

Due to article length and to facilitate ease-of-access, this two part article has been made available for online viewing and download – with copyright removed to allow for elective republication – at the following url:
https://webtel.mobi/pc/info/UnitaryCurrency

The public release of this two-part article occurred at 12:00 London time / 07:00 New York time on March 6, 2023, and the two parts of the article are currently available for public review at the url shown above.

Resources:

To view the Two-Part Article on Webtel.mobi’s existing Unitary Global Digital Currency:
https://webtel.mobi/pc/info/UnitaryCurrency

WM Holdings Inc. website:
https://wmholdings.mobi

Webtel.mobi Platform:
https://webtel.mobi/pc

Contact Webtel.mobi or WM Holdings Inc.:
wm@thoburns.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/c09a82b4-b51c-48da-93fd-ba163b8cb62f

The photo is also available at Newscom, www.newscom.com, and via AP PhotoExpress.

GlobeNewswire Distribution ID 8782086

Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones

INSIDE INFORMATION
REGULATED INFORMATION

Nyxoah Announces Achievement of Key Clinical and Regulatory Milestones
All 115 patients implanted in DREAM U.S. pivotal study
First DREAM PMA module submitted
First patient implanted in ACCCESS U.S. pivotal study

Mont-Saint-Guibert, Belgium – March 6, 2023, 7:30am CET / 1:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company has completed all 115 implants in its DREAM U.S. pivotal study, submitted the first module in the modular PMA submission and implanted the first patient in the ACCCESS U.S. pivotal study.

The DREAM study is a pivotal, investigational device exemption (IDE) trial designed to support the marketing authorization of the Genio® hypoglossal nerve stimulation system (HGNS) in the United States. This multicenter, prospective, open-label, observational study enrolled 115 patients and has co-primary efficacy endpoints of the Apnea-Hypopnea Index (AHI) responder rate, per the Sher criteria, and the Oxygen Desaturation Index (ODI) responder rate, both at 12 months.

In the ACCCESS trial, Nyxoah will implant 106 complete concentric collapse (CCC) patients with co-primary efficacy endpoints of Apnea-Hypopnea Index (AHI) responder rate, per the Sher criteria, and Oxygen Desaturation Index (ODI) responder rate, both assessed at 12 months post-implant.

“The achievement of these key clinical and regulatory milestones brings us closer to offering our patient centric Genio solution to all OSA patients in the U.S. The DREAM and ACCCESS studies demonstrate Nyxoah’s mission of providing Genio to patients regardless of CCC status and without the requirement for a CCC diagnosis,” commented Olivier Taelman, Nyxoah’s Chief Executive Officer.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward-looking statements 
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; future financial performance and market position; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2021, filed with the Securities and Exchange Commission (“SEC”) on March 24, 2022, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:
David DeMartino
Chief Strategy Officer
david.demartino@nyxoah.com
+1 310 310 1313

Attachment

GlobeNewswire Distribution ID 1000796325

Nuvei announces next step in its global expansion plan with Australia launch

Nuvei is enabling eCommerce businesses in the world’s 12th largest economy to accelerate their growth

MONTREAL, March 05, 2023 (GLOBE NEWSWIRE) — Nuvei Corporation (“Nuvei” or the “Company”) (Nasdaq: NVEI) (TSX: NVEI), the Canadian fintech company, announces today that businesses operating in Australia can now access its full suite of market-leading payments solutions including acquiring, processing, alternative payment methods and risk management.

Australian businesses operating locally and globally will benefit from Nuvei’s cutting-edge, agile technology that’s built to accelerate their growth. Nuvei’s payments platform enables businesses to optimize operating costs and boost conversion rates by maximizing payments acceptance, minimizing risk, and enhancing the consumer payment experience. This includes offering all local and relevant payment methods.

Launching in Australia is the latest initiative from Nuvei as it continues to grow its presence and capabilities in the Asia-Pacific (APAC) region, following its successful launch in Singapore and Hong Kong in 2022.

Nuvei Chair and CEO Philip Payer commented on the announcement: “Our mission is to help our customers connect with their customers regardless of location, payment method or currency. Launching in Australia is a natural step for our continued expansion in APAC, having already established a strong and growing presence in the region.”

Nuvei is launching in Australia having secured regulatory and scheme licenses to support customers with local acquiring in the country.

Fayer continued: “We know the role local acquiring plays in payments optimization, which is why Nuvei’s local acquiring network across the globe is unparalleled. Being able to support merchants in Hong Kong, Singapore, and now Australia with local acquiring solutions demonstrates our commitment to our customers’ growth.”

While debit and credit card payments are the preeminent online payment method for Australian consumers, alternative payment methods (APMs) are also growing in popularity. Nuvei technology enables businesses to accept all the relevant payment methods in the region (including local currencies for cross-border transactions) in addition to card acquiring. This includes New Payments Platform (NPP), Australia’s account-to-account fast payments open access infrastructure, giving consumers even more choice over their payments experience.

Benefits of NPP for consumers include instant, 24/7/365 settlements, making this payment method particularly relevant for industries where payouts are critical to the overall payments experience.

Australia is a significant market for eCommerce in APAC and globally. It is the world’s 12th largest economy and had an eCommerce market value of $47bn (with 8.9% growth)[1] in 2022. Internet penetration in Australia is 91%[2] and over 90% of Australian internet users make online purchases.

About Nuvei 

Nuvei (Nasdaq: NVEI) (TSX: NVEI) is the Canadian fintech company accelerating the business of clients around the world. Nuvei’s modular, flexible and scalable technology allows leading companies to accept next-gen payments, offer all payout options and benefit from card issuing, banking, risk and fraud management services. Connecting businesses to their customers in more than 200 markets, with local acquiring in 45+ markets, 150 currencies and more than 600 alternative payment methods, Nuvei provides the technology and insights for customers and partners to succeed locally and globally with one integration.

For more information, visit www.nuvei.com


[1] https://www.savvy.com.au/australias-online-shopping-behaviour-report-2022/#:~:text=Australia’s%20online%20shopping%20industry%20is,retail%20therapy%20continues%20to%20skyrocket

[2] https://www.statista.com/statistics/680142/australia-internet-penetration/

Alex Hammond
Nuvei
alex.hammond@nuvei.com

Investor Relations
Nuvei
IR@nuvei.com

GlobeNewswire Distribution ID 8781827

eXp Realty Paid Over $240 Million in Revenue Share and Equity Benefits to Agents and Brokers in 2022

Aligning the interests of agents and brokers with the company they own is key to eXp Realty’s long-term growth strategy

Revenue Share and Equity Benefits
REVEQSHARE-PR1200x630bl1 (1)

eXp Realty Paid Over $240 Million in Revenue Share and Equity Benefits to Agents and Brokers in 2022

BELLINGHAM, Wash., March 03, 2023 (GLOBE NEWSWIRE) — eXp Realty®, “the most agent-centric real estate brokerage on the planet™” and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today released its 2022 revenue share and agent equity payout figures, demonstrating how its competitive compensation model underpins continued agent growth.

Revenue Share and Equity Paid to Agents and Brokers Continues To Increase Year-over-Year

  • Revenue share to agents increased 20% to $202 million in 2022.
  • eXp Realty distributed more profit/revenue share benefits last year to agents and brokers than any other real estate brokerage model or platform.
  • As part of our agent equity program, eXp World Holdings issued over 2.5 million EXPI shares to eXp Realty agents and brokers valued at more than $42.5 million.

“When eXp Realty was founded, we set out to build the most agent-centric brokerage that solved the biggest pain point in real estate for agents,” said Glenn Sanford, Founder and CEO of eXp Realty. “Historically, agents were generally not offered meaningful ownership in the brokerages they were part of and the profit/revenue sharing models didn’t provide a viable path to potential retirement for the vast majority of agents.

“With this in mind, an important part of building eXp was designing a truly aligned compensation model that rewards agents for their production and contribution to the company’s growth. As we have disclosed in our fourth quarter and full-year 2022 results, our model and core business has proven to be sustainable in both good and bad markets. More importantly, it proves that we are delivering on the promise we made to agents when eXp was founded in 2009. By building the most agent-centric real estate brokerage on the planet, we continue to grow, improving the lives of agents around the world.

All that being said, since becoming a public company in 2013, EXPI’s stock has outperformed all other publicly traded real estate brokerages, franchisors and brokerage/franchisor conglomerates. We also enjoy the highest market cap among all publicly traded residential real estate brokerage platforms, showing once again that focusing on the agent experience isn’t just good for the agent, but it has also been good for long-term shareholders.”

Revenue Share and Equity Benefits Detail
REVEQSHARE-PR1200x630wt1 (1)

Revenue share to agents increased 20% to $202 million in 2022. eXp Realty distributed more profit/revenue share benefits last year to agents and brokers than any other real estate brokerage model or platform. As part of our agent equity program, eXp World Holdings issued over 2.5 million EXPI shares to eXp Realty agents and brokers valued at more than $42.5 million.

About eXp World Holdings, Inc.

eXp World Holdings, Inc. (Nasdaq: EXPI) is the holding company for eXp Realty®, Virbela and SUCCESS® Enterprises.

eXp Realty is the largest independent real estate company in the world with more than 87,000 agents in the United States, Canada, the United Kingdom, Australia, South Africa, India, Mexico, Portugal, France, Puerto Rico, Brazil, Italy, Hong Kong, Colombia, Spain, Israel, Panama, Germany, Dominican Republic, Greece, New Zealand, Chile, Poland and Dubai and continues to scale internationally. As a publicly traded company, eXp World Holdings provides real estate professionals the unique opportunity to earn equity awards for production goals and contributions to overall company growth. eXp World Holdings and its businesses offer a full suite of brokerage and real estate tech solutions, including its innovative residential and commercial brokerage model, professional services, collaborative tools and personal development. The cloud-based brokerage is powered by Virbela, an immersive 3D platform that is deeply social and collaborative, enabling agents to be more connected and productive. SUCCESS® Enterprises, anchored by SUCCESS® magazine and its related media properties, was established in 1897 and is a leading personal and professional development brand and publication.

For more information, visit https://expworldholdings.com.

Safe Harbor Statement
The statements contained herein may include statements of future expectations and other forward-looking statements that are based on management’s current views and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. Such forward-looking statements speak only as of the date hereof, and the company undertakes no obligation to revise or update them. These statements include, but are not limited to, statements about the continued growth of our agent and broker base and expansion of our residential real estate brokerage business into foreign markets. Such statements are not guarantees of future performance. Important factors that may cause actual results to differ materially and adversely from those expressed in forward-looking statements include changes in business or other market conditions; the difficulty of keeping expense growth at modest levels while increasing revenues; and other risks detailed from time to time in the company’s Securities and Exchange Commission filings, including but not limited to the most recently filed Quarterly Report on Form 10-Q and Annual Report on Form 10-K.

Media Relations Contact:
Jennifer Zimmerman
eXp World Holdings, Inc.
mediarelations@expworldholdings.com

Investor Relations Contact:
Denise Garcia, Managing Partner
Hayflower Partners
investors@expworldholdings.com

Photos accompanying this announcement are available at

https://www.globenewswire.com/NewsRoom/AttachmentNg/e0d795ac-5bdd-4f9c-af3d-3f470035652e

https://www.globenewswire.com/NewsRoom/AttachmentNg/15708f42-8fb1-46df-b714-aebb17bf171a

GlobeNewswire Distribution ID 8781588

Copenhagen Infrastructure Partners enters long-term partnership in India to develop 1.8GW of renewable energy projects

Copenhagen Infrastructure Partners (CIP), on behalf of its New Markets Fund I (CI NMF I), today announced a partnership with Indian developer Viviid Renewables to develop more than 1.8GW of greenfield renewable energy projects in India.

COPENHAGEN, Denmark, March 03, 2023 (GLOBE NEWSWIRE) — Copenhagen Infrastructure Partners has entered into a framework agreement through its Copenhagen Infrastructure New Markets Fund I (CI NMF I) with Viviid Renewables Private Limited, an Indian developer and BOP contractor, to develop more than 1.8GW of renewable energy projects in India with a primary focus on onshore wind projects.

The partnership will initially focus on the development of two onshore wind projects with a combined capacity exceeding 500MW, with additional projects expected to be developed and constructed through successor CI NMF funds. Viviid will contribute projects from its extensive development pipeline to the partnership, as well as deliver key development activities up to Final Investment Decision as well as providing design, engineering, procurement, and construction services. CIP will lead offtake sourcing, general procurement activities and the financing process while leveraging Viviid’s local experience.

Peter Sjøntoft, Associate Partner in CIP, commented: “This is the second CI NMF I partnership in the Indian renewable energy market, reflecting India’s continuing importance as a key focus area for the fund. With this partnership we are significantly strengthening our foothold in India and are delighted to partner with Viviid and look forward to working alongside their highly experienced team, combining our joint expertise to assist the green transition in the country.”

Siddharth Mehra, founder of Viviid, commented: “We are very excited to be partnering with CIP to accelerate delivery of our project pipeline over the coming years. Through this long-term partnership, we aim to further strengthen our contribution to India’s ambitious target of installing 500GW of generation capacity from renewable sources by 2030.”

About Copenhagen Infrastructure Partners
Founded in 2012, Copenhagen Infrastructure Partners P/S (CIP) today is the world’s largest dedicated fund manager within greenfield renewable energy investments and a global leader in offshore wind. The funds managed by CIP focuses on investments in offshore and onshore wind, solar PV, biomass and energy-from-waste, transmission and distribution, reserve capacity, storage, advanced bioenergy, and Power-to-X.

CIP manages ten funds and has to date (March 2023) raised approximately EUR 19 billion for investments in energy and associated infrastructure from more than 140 international institutional investors. CIP has approximately 400 employees and 11 offices around the world. For more information, visit www.cip.com

About Viviid Renewables
Viviid Renewables Private Limited, is one of the leading renewable energy developers in India with an established track record and with many large projects under construction with leading IPPs. Viviid provides end-to-end development and BOP services for wind and solar projects across India. For more information, visit http://www.viviidrenewables.com/

For further information, please contact:
Copenhagen Infrastructure Partners 
Simon Mehl Augustesen, Chief Communication Officer
Phone: +45 3052 6721
Email: siau@cip.dk 

Thomas Kønig, Partner – Investor Relations
Phone: +45 7070 5151
Email: tkon@cip.dk 

GlobeNewswire Distribution ID 1000795981

Civil society groups launch Global Charter for Fisheries Transparency at 2023 Our Ocean conference

The launch of the Charter by the Coalition for Fisheries Transparency lays out a new roadmap to advance marine governance around the world.

PANAMA CITY, Panama, March 02, 2023 (GLOBE NEWSWIRE) — The Coalition for Fisheries Transparency – a new international community of civil society organizations – today launched the Global Charter for Fisheries Transparency. The Charter pinpoints the most essential policy priorities needed to combat fisheries mismanagement, illegal fishing, and human rights abuses at sea. Experts, ministers, and delegates from international organizations and companies around the world discussed the benefits of the Global Charter for Fisheries Transparency at Our Ocean conference in Panama this Thursday and Friday – an annual meeting for countries, civil society and industry to announce significant actions to safeguard the world’s oceans.

“Ghana recognizes the critical role that transparency plays in the fight against illegal fishing to protect livelihoods and provide food security to our coastal communities,” said Hon. Mavis Hawa Koomson, Ghana’s Minister of Fisheries and Aquaculture Development. “With the significant progress Ghana has made in the last year on ending harmful fishing practices that have encouraged illegal fishing in our waters, we are now working towards making greater efforts towards sustaining fisheries transparency in Ghana.”

Prof. Maxine Burkett, Deputy Assistant Secretary for Oceans, Fisheries and Polar Affairs at the U.S. Department of State, highlighted how the U.S. plays a leading role in increasing transparency in global fisheries.

“Last year, President Biden released a National Security Memorandum that recognizes the importance of transparency for combating illegal, unreported, and unregulated (IUU) fishing and associated forced labor abuses,” she said. “By enhancing productive information-sharing, the Global Charter for Fisheries Transparency will serve as an important complement to the U.S. government’s activities to end IUU fishing through improving fisheries and ocean governance, increasing enforcement efforts, and raising ambition to end IUU fishing globally.

Additionally, global partnership initiatives, like the Fisheries Transparency Initiative (FiTI), emphasized the importance of equal, multi-stakeholder collaboration to increase transparency in coastal countries for achieving sustainably managed marine fisheries.

“Given the complexity of fisheries governance, multiple transparency efforts are needed to address the various challenges of unsustainable marine fisheries, such as overfishing, IUU fishing, unequal access to fisheries resources, and unfair benefit sharing,” said Dr. Valeria Merino, Chair of the International Board of the Fisheries Transparency Initiative (FiTI). “The 10 principles of the Global Charter for Fisheries Transparency recognize the need for a comprehensive and coordinated approach to fisheries transparency, and has the potential to support existing global endeavors, such as the FiTI, through a much-needed mobilization of civil society organizations to ensure that marine fishing activities are legal, ethical, and sustainable.”

Finally, the role of the civil society to maximize collective impact to improve transparency has been underlined by Mr. Wakao Hanaoka, Chief Executive Officer of Seafood Legacy (Japan), and a steering committee member of the Coalition for Fisheries Transparency. “Our membership in the Coalition for Fisheries Transparency represents a voice of an international community that allows us to strengthen and amplify our efforts amongst the seafood industry and government towards achieving our goal of making Japan a global leader in environmental sustainability and social responsibility,” he explained.

The Global Charter for Fisheries Transparency lays out a new roadmap to advance marine governance internationally, by providing a set of advocacy principles that are both effective and achievable by all stakeholders involved in fisheries governance and management.

“Continuous advocacy efforts by civil society organizations are critical to improving fisheries governance internationally as well as protecting the ocean and the people who depend on its resources,” commented Maisie Pigeon, Director of the Coalition for Fisheries Transparency. “The Coalition’s mission to deliver an urgent shift towards greater transparency in fisheries will be achieved through supporting our members in developing joint strategies, harmonizing and strengthening efforts, and finally – closing transparency policy gaps in fisheries governance,” she concluded.

Through civil society organizations from around the world, the Coalition for Fisheries Transparency calls on governments to apply the Charter’s principles in legislation and practice.

Press contact: Agata Mrowiec agata@fisheriestransparency.net +34 608 517 552

GlobeNewswire Distribution ID 8780726

Constellation Brands to Report Full Fiscal Year and Fourth Quarter 2023 Financial Results; Host Conference Call April 6, 2023

VICTOR, N.Y., March 02, 2023 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today it will report financial results for its full fiscal year and fourth quarter ended February 28, 2023, on Thursday, April 6, 2023, before the open of the U.S. markets. A conference call to discuss the financial results and outlook will be hosted by President and Chief Executive Officer, Bill Newlands, and Executive Vice President and Chief Financial Officer, Garth Hankinson, at 10:30 a.m. EDT, April 6, 2023.

The conference call can be accessed by dialing +1-877-407-9121 and entering conference identification number 13736556, beginning at 10:20 a.m. EDT. A live, listen-only webcast of the conference call will be available on the company’s investor relations website at ir.cbrands.com under the News & Events section. When the call begins, financial information discussed on the conference call, and a reconciliation of reported GAAP financial measures with comparable or non-GAAP financial measures, will also be available on the company’s investor relations website under the Financial History section. For anyone unable to participate in the conference call, a replay will be available on the company’s investor relations website.

ABOUT CONSTELLATION BRANDS
At Constellation Brands (NYSE: STZ), our mission is to build brands that people love because we believe sharing a toast, unwinding after a day, celebrating milestones, and helping people connect, are Worth Reaching For. It’s worth our dedication, hard work, and the bold calculated risks we take to deliver more for our consumers, trade partners, shareholders, and communities in which we live and work. It’s what has made us one of the fastest-growing large CPG companies in the U.S. at retail, and it drives our pursuit to deliver what’s next.

Today, we are a leading international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy. Every day, people reach for our high-end, iconic imported beer brands such as Corona Extra, Corona Light, Corona Premier, Modelo Especial, Modelo Negra, and Pacifico, our fine wine and craft spirits brands, including The Prisoner Wine Company, Robert Mondavi Winery, Casa Noble Tequila, and High West Whiskey, and our premium wine brands such as Meiomi, and Kim Crawford.

But we won’t stop here. Our visionary leadership team and passionate employees from barrel room to boardroom are reaching for the next level, to explore the boundaries of the beverage alcohol industry and beyond. Join us in discovering what’s Worth Reaching For.

To learn more, visit www.cbrands.com and follow us on Twitter, Instagram, and LinkedIn.

MEDIA CONTACTS INVESTOR RELATIONS CONTACTS
Mike McGrew 773-251-4934 / michael.mcgrew@cbrands.com
Amy Martin 585-678-7141 / amy.martin@cbrands.com
Joseph Suarez 773-551-4397 / joseph.suarez@cbrands.com
Snehal Shah 847-385-4940 / snehal.shah@cbrands.com
David Paccapaniccia 585-282-7227 / david.paccapaniccia@cbrands.com

A downloadable PDF copy of this news release can be found here. http://ml.globenewswire.com/Resource/Download/aae87911-3ca8-4427-a51a-37de20cf9b57

GlobeNewswire Distribution ID 8780615

Iveco Group publishes its 2022 Annual Report and calls the Annual General Meeting

Turin, 2nd March 2023. Iveco Group N.V. (MI: IVG) announced that it filed today its 2022 Annual Report with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF). The document is available in the Investors section of the Iveco Group corporate website at www.ivecogroup.com.

Iveco Group’s Annual Report for the year ended 31st December 2022 will be on the agenda of the Annual General Meeting of its Shareholders (AGM), that will be held in Amsterdam on 14th April 2023 at 11:30 a.m. CEST. In addition, the agenda of the AGM includes the discussion of the Company’s dividend policy, the remuneration report (advisory voting only), the granting of discharge to the members of the Board, the re-appointment of the Executive and Non-Executive Directors, the authorization to the Board to acquire Common Shares in the Company.

The Notice of the AGM, the Agenda and the relevant Explanatory Notes, the instructions for voting, and other AGM materials were also published today and are available on the Company’s website at www.ivecogroup.com, where they can be viewed and downloaded.

Iveco Group N.V. (MI: IVG) is the home of unique people and brands that power your business and mission to advance a more sustainable society. The eight brands are each a major force in its specific business: IVECO, a pioneering commercial vehicles brand that designs, manufactures, and markets heavy, medium, and light-duty trucks; FPT Industrial, a global leader in a vast array of advanced powertrain technologies in the agriculture, construction, marine, power generation, and commercial vehicles sectors; IVECO BUS and HEULIEZ, mass-transit and premium bus and coach brands; IDV, for highly-specialised defence and civil protection equipment; ASTRA, a leader in large-scale heavy-duty quarry and construction vehicles; MAGIRUS, the industry-reputed firefighting vehicle and equipment manufacturer; and IVECO CAPITAL, the financing arm which supports them all. Iveco Group employs approximately 34,000 people around the world and has 28 manufacturing plants and 29 R&D centres. Further information is available on the Company’s website www.ivecogroup.com

Media Contacts:
Francesco Polsinelli, Mob: +39 335 1776091
Fabio Lepore, Mob: +39 335 7469007
E-mail: mediarelations@ivecogroup.com

Investor Relations:
Federico Donati, Tel: +39 011 0073539
E-mail: investor.relations@ivecogroup.com

Attachment

GlobeNewswire Distribution ID 1000795936